Total Payments
$10,749
2024 Payments
$290.88
Companies
36
Transactions
152
Medicare Patients
2,524
Medicare Billing
$219,004
Payment Breakdown by Category
Research$4,175 (38.8%)
Food & Beverage$3,496 (32.5%)
Travel$2,942 (27.4%)
Education$136.40 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4,175 | 1 | 38.8% |
| Food and Beverage | $3,496 | 141 | 32.5% |
| Travel and Lodging | $2,942 | 6 | 27.4% |
| Education | $136.40 | 4 | 1.3% |
Payments by Type
General
$6,574
151 transactions
Research
$4,175
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $4,175 | 1 | $0 (2017) |
| The Spectranetics Corporation | $1,584 | 4 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $1,474 | 7 | $0 (2017) |
| Insmed, Inc. | $542.98 | 20 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $385.99 | 13 | $0 (2020) |
| GlaxoSmithKline, LLC. | $365.63 | 29 | $0 (2023) |
| Edwards Lifesciences Corporation | $262.30 | 2 | $0 (2023) |
| Genentech USA, Inc. | $194.95 | 5 | $0 (2021) |
| JAZZ PHARMACEUTICALS INC. | $177.49 | 4 | $0 (2024) |
| Inari Medical, Inc. | $170.35 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $290.88 | 9 | Axsome Therapeutics, Inc. ($123.23) |
| 2023 | $346.03 | 6 | Edwards Lifesciences Corporation ($230.93) |
| 2022 | $94.45 | 4 | Organogenesis Inc. ($40.14) |
| 2021 | $140.94 | 8 | Edwards Lifesciences Corporation ($31.37) |
| 2020 | $296.77 | 11 | Insmed, Inc. ($198.76) |
| 2019 | $1,343 | 41 | Insmed, Inc. ($315.02) |
| 2018 | $523.29 | 24 | Boehringer Ingelheim Pharmaceuticals, Inc. ($162.98) |
| 2017 | $7,714 | 49 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($4,175) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Respiratory | ||||||
| 06/24/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $30.84 | General |
| Category: NEUROLOGY | ||||||
| 06/19/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Respiratory | ||||||
| 04/24/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $123.23 | General |
| Category: Neurology | ||||||
| 11/15/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $30.09 | General |
| Category: PAH | ||||||
| 11/09/2023 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Infectious Diseases | ||||||
| 11/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: RESPIRATORY | ||||||
| 10/12/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $26.80 | General |
| Category: SLEEP MEDICINE | ||||||
| 07/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: RESPIRATORY | ||||||
| 06/06/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $230.93 | General |
| 07/13/2022 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $40.14 | General |
| Category: WOUND CARE | ||||||
| 03/07/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: IMMUNOLOGY | ||||||
| 02/08/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Respiratory | ||||||
| 01/06/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Respiratory | ||||||
| 07/19/2021 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Immunology | ||||||
| 06/30/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: RESPIRATORY | ||||||
| 06/16/2021 | Edwards Lifesciences Corporation | HemoSphere (Device) | Food and Beverage | In-kind items and services | $31.37 | General |
| Category: Hemodynamic Monitoring | ||||||
| 05/06/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: Respiratory | ||||||
| 04/28/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Respiratory | ||||||
| 04/26/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Education | In-kind items and services | $12.00 | General |
| Category: ANTIBIOTIC | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| REAL-WORLD DETECTION AND SUCCESSFUL MANAGEMENT OF MANAGEMENT OF H. PYLORI IN AN INTEGRATED DELIVERY NETWORK DATABASE IN THE UNITED STATES | Otsuka Pharmaceutical Development & Commercialization, Inc. | $4,175 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 630 | 679 | $148,792 | $40,437 |
| 2022 | 14 | 680 | 779 | $214,889 | $57,160 |
| 2021 | 15 | 612 | 720 | $205,724 | $58,301 |
| 2020 | 17 | 602 | 728 | $214,233 | $63,107 |
Total Patients
2,524
Total Services
2,906
Medicare Billing
$219,004
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 25 | 41 | $23,165 | $6,467 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 64 | $13,463 | $5,479 | 40.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 58 | 59 | $25,606 | $4,535 | 17.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 74 | $10,704 | $4,165 | 38.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 58 | 58 | $11,952 | $4,084 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $8,190 | $2,890 | 35.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 49 | $7,301 | $2,860 | 39.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 30 | 30 | $12,990 | $2,638 | 20.3% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 87 | 87 | $13,833 | $2,623 | 19.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 61 | 61 | $7,687 | $2,058 | 26.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 41 | 41 | $5,735 | $906.84 | 15.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 48 | 49 | $4,095 | $703.78 | 17.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 16 | 16 | $1,620 | $518.84 | 32.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 13 | 13 | $1,406 | $310.57 | 22.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 11 | 11 | $1,045 | $198.56 | 19.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 53 | 114 | $64,410 | $18,987 | 29.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 81 | 81 | $35,154 | $6,729 | 19.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 104 | $14,976 | $5,443 | 36.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 39 | 68 | $14,552 | $5,196 | 35.7% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2022 | 141 | 141 | $22,419 | $4,173 | 18.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 59 | 59 | $25,547 | $4,108 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 45 | $9,405 | $3,925 | 41.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $5,974 | $2,071 | 34.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 18 | $4,986 | $1,843 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,410 | $1,545 | 35.0% |
About Dr. Mohammad Ansari, M.D
Dr. Mohammad Ansari, M.D is a Critical Care Medicine healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821047044.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Ansari, M.D has received a total of $10,749 in payments from pharmaceutical and medical device companies, with $290.88 received in 2024. These payments were reported across 152 transactions from 36 companies. The most common payment nature is "" ($4,175).
As a Medicare-enrolled provider, Ansari has provided services to 2,524 Medicare beneficiaries, totaling 2,906 services with total Medicare billing of $219,004. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Sleep Medicine, Pulmonary Disease
- Location Greenville, SC
- Active Since 05/06/2006
- Last Updated 07/19/2021
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1821047044
Products in Payments
- BREATHTEK (Device) $1,465
- ELCAELCA X-80 (Device) $1,445
- Arikayce (Drug) $542.98
- FlowTriever (Device) $170.35
- TURBOELITE (Device) $138.99
- DUPIXENT (Biological) $133.34
- NUCALA (Biological) $129.03
- Sunosi (Drug) $123.23
- remede System (Device) $121.65
- ZERBAXA (Drug) $116.31
- ANORO (Drug) $111.97
- Xyrem (Drug) $108.44
- OFEV (Drug) $89.76
- LONHALA MAGNAIR (Drug) $86.54
- TRELEGY ELLIPTA (Drug) $78.85
- FASENRA (Biological) $72.28
- Aquadex (Device) $60.15
- Esbriet (Biological) $50.46
- TUDORZA PRESSAIR (Drug) $49.71
- Cresemba (Drug) $47.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Greenville
Nasir Awan, M.d, M.D
Critical Care Medicine — Payments: $34,640
Critical Care Medicine $34,640
Dr. Mohan Philip, M.d, M.D
Critical Care Medicine — Payments: $8,379
Critical Care Medicine $8,379
Charles Mullen, Md, MD
Critical Care Medicine — Payments: $7,075
Critical Care Medicine $7,075
Ahmad Boota, Md, MD
Critical Care Medicine — Payments: $4,026
Critical Care Medicine $4,026
Kimberly Smith, Rn, RN
Critical Care Medicine — Payments: $3,640
Critical Care Medicine $3,640
Dr. Christy Sine, Md, MD
Critical Care Medicine — Payments: $3,525
Critical Care Medicine $3,525